Bookmark and Share

Last Minute: "Boris Johnson defends Northern Ireland protocol bill ahead of Commons vote - The Guardian" Mon, 27 Jun 2022 13:33:00 GMT   "Ukraine war: Missiles hit shopping centre with over 1,000 people inside in city of Kremenchuk, Zelenskyy says - Sky News" Mon, 27 Jun 2022 14:54:03 GMT    "Birmingham: Woman found dead and man left with life threatening injuries after house destroyed in gas explosion - Sky News" Mon, 27 Jun 2022 13:37:34 GMT    "Ilford murder: Manhunt after woman ambushed and killed in east London street - Evening Standard" Mon, 27 Jun 2022 13:51:40 GMT    "Barristers walk out of courts in strike over pay - BBC" Mon, 27 Jun 2022 14:08:11 GMT    "Nato increases forces on high alert from 40,000 to more than 300,000 amid Russia threat - The Independent" Mon, 27 Jun 2022 14:00:29 GMT    "Russia set for first debt default since 1998 as payment deadline passes - Financial Times" Mon, 27 Jun 2022 10:37:16 GMT    "Boris Johnson hit by new letters of no confidence from Tory MPs - The Telegraph" Sun, 26 Jun 2022 20:30:00 GMT    "Ex-Hollywood actor who fell into life of crime burgles home after missing last bus while drunk - Manchester Evening News" Mon, 27 Jun 2022 07:12:36 GMT    "'Dangerous' and violent man jailed for 'most appalling campaign of abuse' court had ever seen - Sky News" Mon, 27 Jun 2022 06:23:58 GMT      For more news, click here.

Authentication
       
       
Remember me? 

Rise of
+3.85 (+1.24%) Biogen Idec Inc. - [Ticker: BIIB]Chart Biogen Idec Inc.  News Biogen Idec Inc.  Download Historical Prices for Metastock Biogen Idec Inc. and Others  Technical Analysis Biogen Idec Inc.  
Last Trade315.51Last Trade Time2017-11-01 - 19:35:00
Variation+3.85 (+1.24%)Open312.75
High319.95Low311.57
Volume1,047,609Average Volume (3m)0
YieldBid / Ask315.47 x 300 - 315.59 x 200
Former Close311.6652 Week Range[0.00 - 0.00]
PER0.00%EPS0.00
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.
Watch more quotes

Intraday   5 days   1 month   3 months   6 months   1 year   2 years   5 years   10 years            Use this chart on your website!
Biogen Idec Inc. -  [Ticker: BIIB] chart
Change to Biogen Idec Inc. Interactive Technical Analysis Chart

Last 10 Forum Topics about Biogen Idec Inc.:
No topics about Biogen Idec Inc. [BIIB] have been found, but a search on the Forum for more topics related to Biogen Idec Inc. is advised.

 News about Biogen Idec Inc. [BIIB]:   (ordered by relevance)
FDCA-Based Negligence Per Se & Informed Consent Don't Mix  Lexology Neuropathic Pain Market Is Booming Worldwide 2022-2028 | Pfizer, Inc., Johnson & Johnson Services, Inc., Sanofi S.A., Eily Lily and Company, GlaxoSmithKline PLC, Biogen Idec  Digital Journal Global Remicade Biosimilar Market Status, Leading Key Players, Growth Opportunities and Future Forecasts 2022-2028 ? Designer Women  Designer Women Orphan Drugs Market Size, Scope and Forecast | Celgene Corporation, Hoffmann- La Roche, Bristol-Myers Squibb, Alexion Pharmaceuticals, Inc., Biogen Idec Limited, Novartis AG, Vertex Pharmaceuticals, Inc., Takeda Pharmaceuticals Company Limited ? D  Designer Women Recombinant Coagulation Factors Market 2022 Global Competition by Opportunity Assessment and Forecast by 2028: Baxter International, Bayer, Biogen Idec, CSL, Grifols International, Kedrion S.P.A.  Digital Journal Subcutaneous Biologics Market See Huge Growth for New Normal | Abbott Laboratories, Pfizer Inc., Genentech Inc. ? Designer Women  Designer Women Hemoglobinopathies Drugs Market: 2022 Share, Size, Future Demand, Trends, Region by Forecast to 2030 ? Indian Defence News  Indian Defence News Global Gastric Cancer Testing, Treatment and Prevention Market 2022 Research Report Analysis ? Biogen Idec, Bristol Myers Squibb, Eli Lilly And Company, Glaxosmithkline Genentech Inc ? Designer Women  Designer Women In-depth Research on Cognition-Enhancing Drugs Market Forecast ? Estimation & Approach 2022-2028 | Accelerated Intelligence, Cognition Therapeutics, Cogstate, HVMN, Biogen Idec,, and more | Affluence ? Indian Defence News  Indian Defence News Protein Drugs Market 2022 Key Players, Industry Overview, Supply Chain and Analysis to 2028 -Eli Lilly, Abbott Laboratories ? Designer Women  Designer Women Multiple Sclerosis Ms Drugs Market is Likely to Expand at Promising CAGR with| Bayer AG, Bayhill Therapeutics, Biogen Idec ? Indian Defence News  Indian Defence News Nephropathy Medicine Market Size, Status, Precise Outlook 2022 To 2028 | Shionogi Inc., Sanofi-aventis, Genzyme Corporation, Bayer ? Designer Women  Designer Women Will Biogen Stock Rise After The Recent 6% Fall?  Forbes Oligonucleotide Synthesis Market Size Worth USD 9.91 Billion by 2027 | Emergen Research Study  EIN News Bio-Pharma Market 2022 Top Key Players, Demands, Trends and Forecasts to 2030 ? Indian Defence News  Indian Defence News Follow-On-Biologics Market 2022 Top Key Players, Demands, Trends and Forecasts to 2030 ? Indian Defence News  Indian Defence News Kinase Inhibitors Market 2022 Top Key Players, Demands, Trends and Forecasts to 2030 ? Indian Defence News  Indian Defence News Antibody Drugs Market 2022 Top Key Players, Demands, Trends and Forecasts to 2030 ? Indian Defence News  Indian Defence News Splice Enclosures Market Competition Outlook & Key Statistics by Nexans, PLP, Raychem, FIS, Micos Telcom, Furukawa Electric, and more ? Indian Defence News  Indian Defence News Biogen's roller coaster 2021 takes another surprising turn with report of $42B Samsung buyout interest  FiercePharma Biogen | Newsroom  Biogen Biogen Stock: Will This Second Bite At The Alzheimer's Apple Payoff?  Investor's Business Daily Biogen Idec: A Great Company, But Not An Alpha Opportunity (NASDAQ:BIIB)  Seeking Alpha Biogen Drops Idec From Name - WSJ  The Wall Street Journal Workable Strategic Report on Solid Tumors Treatment Market by Forecast to 2027 with Covered Top Companies like Abbott Laboratories Inc., Biogen Idec Incorporated, AstraZeneca Plc  Medgadget Cancer Antibody Drug Conjugates Market Trends Analysis,Top Manufacturers,Shares,Growth Opportunities,Statistic  openPR Here?s Why Biogen Stock Can Offer Over 35% Gains  Forbes Biogen Sells Bioepis Stake for $2.3 Billion to Samsung Biologics  JD Supra Alzheimer's drug from Biogen wins US approval  Financial Times The Architect Of Biogen's Controversial Alzheimer's Strategy, Al Sandrock, To Retire  Scrip Subcutaneous Biologics Market will generate new growth opportunities 2022-2028 | Genentech, Biogen Idec, F. Hoffmann-La Roche AG  Digital Journal Biogen Idec and Genentech Tweak Anti-CD20 Alliance to Prevent Future Squabbles  Genetic Engineering & Biotechnology News Movers & Shakers, March 11 | BioSpace  BioSpace BIIB Stock Forecast, Price & News (Biogen)  MarketBeat Biogen/Samsung Approval of BYOOVIZ? | Goodwin - JDSupra  JD Supra Exclusive: Biogen prices hemophilia drug on par with older therapies  Reuters.com Biogen Idec's Strategy For Neurology RD Success  Life Science Leader Magazine Interferon Beta Drugs Market Size Is Anticipated To Reach US$ 4,825.8 Million at a CAGR of 3.5% By 2027 | Biogen Idec., Merck KGaA, Novartis Pharmaceuticals Corporation, and Bayer.  Medgadget Biogen Idec provides coach commuting for suburban workers  The Boston Globe How Biogen Makes Money: Treatments for Neurological Disorders  Investopedia Biogen Stock: With Alzheimer's Treatment In FDA Court, Is BIIB Stock A Buy In January 2021?  Investor's Business Daily Could Vertex Pharmaceuticals Be a Prime Acquisition Target?  The Motley Fool Biogen to pay Forward Pharma $1.25 billion to protect MS drug  Reuters.com
For more news about Biogen Idec Inc. click here:
Biogen Idec Inc. News
Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2022 - TR4DER.com, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources